109 related articles for article (PubMed ID: 10750985)
1. Abnormal uptake of I-131 mimicking salivary gland uptake in a patient with diffuse dental disease.
Morgan R; Cote M
Clin Nucl Med; 2000 Apr; 25(4):314-5. PubMed ID: 10750985
[No Abstract] [Full Text] [Related]
2. Salivary gland scintigraphy after radioiodine therapy.
Malpani BL; Samuel AM; Jaiswar RK
Nucl Med Commun; 1998 Feb; 19(2):183-4. PubMed ID: 9548203
[No Abstract] [Full Text] [Related]
3. The biodistribution of radioiodine on posttherapy iodine-131 scans in thyroid cancer patients with chronic renal failure.
Aktaş A; Kavak K; Kocabaş B; Aras M; Tütüncü NB; Gençoğlu A
Nucl Med Commun; 2008 Nov; 29(11):943-8. PubMed ID: 18836371
[TBL] [Abstract][Full Text] [Related]
4. [Salivary gland function after radioiodine therapy of thyroid cancer].
Sorokin IN; Prikhod'ko AG; Kruglikov IL
Med Radiol (Mosk); 1989 Dec; 34(12):12-4. PubMed ID: 2557521
[No Abstract] [Full Text] [Related]
5. Increased uptake on I-131 whole-body scintigraphy in Warthin tumor despite false-negative Tc-99m pertechnetate salivary gland scintigraphy.
Caglar M; Tuncel M; Usubutun A
Clin Nucl Med; 2003 Nov; 28(11):945-6. PubMed ID: 14578721
[TBL] [Abstract][Full Text] [Related]
6. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine.
Malpani BL; Samuel AM; Ray S
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):535-40. PubMed ID: 8655377
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis.
Lv X; Yin L; Wu W; Li N; Zhang R; Li X; Jia Q; Tan J; Wang P; Zheng X; He X; Huang C; Li D; Wang Y; Meng Z
J Healthc Eng; 2022; 2022():7640405. PubMed ID: 35463665
[TBL] [Abstract][Full Text] [Related]
8. Re: does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Lam MG; van Isselt JW
J Nucl Med; 2005 Dec; 46(12):2118; author reply 2118-9. PubMed ID: 16330579
[No Abstract] [Full Text] [Related]
9. A Randomized Controlled Trial for the Effectiveness of Aromatherapy in Decreasing Salivary Gland Damage following Radioactive Iodine Therapy for Differentiated Thyroid Cancer.
Nakayama M; Okizaki A; Takahashi K
Biomed Res Int; 2016; 2016():9509810. PubMed ID: 28042578
[No Abstract] [Full Text] [Related]
10. Prediction of the success of thyroid remnant ablation using preablative 99mTc pertechnetate scintigraphy and postablative dual 131I scintigraphy.
Jung JS; Lee SM; Kim SJ; Choi J; Han SW
Nucl Med Commun; 2015 Jan; 36(1):38-44. PubMed ID: 25299469
[TBL] [Abstract][Full Text] [Related]
11. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.
Wu JQ; Feng HJ; Ouyang W; Sun YG; Chen P; Wang J; Xian JL; Huang LH
Nucl Med Commun; 2015 Aug; 36(8):819-26. PubMed ID: 25932534
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Parotid Salivary Gland Echo Texture by Ultrasound Examinations and Correlation With Whole-Body Scintigraphy After Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma.
Simões Lima GA; López RVM; de Freitas RMC; Willegaignon J; Sapienza MT; Chammas MC; Coura-Filho GB
J Ultrasound Med; 2020 Sep; 39(9):1811-1818. PubMed ID: 32309884
[TBL] [Abstract][Full Text] [Related]
13. Radioactive iodine and the salivary glands.
Mandel SJ; Mandel L
Thyroid; 2003 Mar; 13(3):265-71. PubMed ID: 12729475
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland protection with sialagogues: a case study.
Van Nostrand D; Atkins F; Bandaru VV; Chennupati SP; Moreau S; Burman K; Wartofsky L
Thyroid; 2009 Sep; 19(9):1005-8. PubMed ID: 19500022
[TBL] [Abstract][Full Text] [Related]
15. Nuclear medicine in diagnosis and treatment of diseases of the head and neck: II.
Blahd WH; Rose JG
Head Neck Surg; 1982; 4(3):213-26. PubMed ID: 7040309
[TBL] [Abstract][Full Text] [Related]
16. Advancements in the diagnosis and treatment of differentiated thyroid cancer.
Stack BC
Clin Med Res; 2003 Jan; 1(1):3. PubMed ID: 15931277
[No Abstract] [Full Text] [Related]
17. Thyroid stunning.
Medvedec M
J Nucl Med; 2001 Jul; 42(7):1129-31. PubMed ID: 11438638
[No Abstract] [Full Text] [Related]
18. Thyroid stunning after (131)I diagnostic whole-body scanning.
McMenemin RM; Hilditch TE; Dempsey MF; Reed NS
J Nucl Med; 2001 Jun; 42(6):986-7. PubMed ID: 11390566
[No Abstract] [Full Text] [Related]
19. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
Lee SM; Lee JW; Kim SY; Han SW; Bae WK
Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
[TBL] [Abstract][Full Text] [Related]
20. Do we read carefully?
Medvedec M
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):475-6. PubMed ID: 12634977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
